Toxicol Sci:通过下调IL-7受体/ Pax5信号,钨阻断小鼠B淋巴细胞分化和增殖

2019-03-27 不详 网络

钨是一种与几种儿科白血病群相关的新兴环境毒物,尽管尚未建立起因果关系。我们之前的研究表明,钨暴露导致骨髓中前B细胞的积累,这种细胞类型在小儿急性淋巴细胞白血病(ALL)中累积。为了更好地理解相关的分子机制,我们对来自对照和暴露于钨的小鼠的流式分选的前B细胞进行了RNA测序。结果显示,钨降低了对B细胞发育至关重要的多个基因的表达,包括IL-7R和前BCR信号传导途径的成员,例如Jak1,Stat5a

钨是一种与几种儿科白血病群相关的新兴环境毒物,尽管尚未建立起因果关系。我们之前的研究表明,钨暴露导致骨髓中前B细胞的积累,这种细胞类型在小儿急性淋巴细胞白血病(ALL)中累积。

为了更好地理解相关的分子机制,我们对来自对照和暴露于钨的小鼠的流式分选的前B细胞进行了RNA测序。结果显示,钨降低了对B细胞发育至关重要的多个基因的表达,包括IL-7R和前BCR信号传导途径的成员,例如Jak1,Stat5a,Pax5,Syk和Ikzf3。这些结果在B细胞分化的体外模型中得到证实,其中钨在pro-B细胞阶段停止分化并抑制增殖。这些变化与IL-7R信号传导通路中多个基因的表达降低和IL-7R,磷酸化STAT5(pSTAT5)双阳性细胞的百分比降低相关。补充IL-7或过表达Pax5(IL-7R下游的转录因子)拯救了钨诱导的分化阻滞。

总之,这些数据支持IL-7R/Pax5信号轴对于钨介导的对B细胞前期发育的影响至关重要的假设。

原始出处:

Wu T, Bolt AM, et al., Tungsten Blocks Murine B Lymphocyte Differentiation and Proliferation Through Downregulation of IL-7 Receptor/Pax5 Signaling. Toxicol Sci. 2019 Mar 26. pii: kfz080. doi: 10.1093/toxsci/kfz080.

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1710183, encodeId=6ce71e1018399, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Sat Aug 31 02:30:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755579, encodeId=73c41e55579fe, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Thu Oct 17 10:30:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302238, encodeId=0ce3130223878, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570269, encodeId=08b415e0269f9, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1710183, encodeId=6ce71e1018399, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Sat Aug 31 02:30:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755579, encodeId=73c41e55579fe, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Thu Oct 17 10:30:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302238, encodeId=0ce3130223878, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570269, encodeId=08b415e0269f9, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1710183, encodeId=6ce71e1018399, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Sat Aug 31 02:30:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755579, encodeId=73c41e55579fe, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Thu Oct 17 10:30:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302238, encodeId=0ce3130223878, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570269, encodeId=08b415e0269f9, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1710183, encodeId=6ce71e1018399, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97676, encryptionId=7ac59e67604, topicName=阻断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca31824852, createdName=41514497@qq.com, createdTime=Sat Aug 31 02:30:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755579, encodeId=73c41e55579fe, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Thu Oct 17 10:30:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302238, encodeId=0ce3130223878, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570269, encodeId=08b415e0269f9, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Fri Mar 29 08:30:00 CST 2019, time=2019-03-29, status=1, ipAttribution=)]